NM_005228.5:c.2283+69G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005228.5(EGFR):c.2283+69G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0222 in 1,243,416 control chromosomes in the GnomAD database, including 389 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.019 ( 33 hom., cov: 33)
Exomes 𝑓: 0.023 ( 356 hom. )
Consequence
EGFR
NM_005228.5 intron
NM_005228.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.724
Publications
6 publications found
Genes affected
EGFR (HGNC:3236): (epidermal growth factor receptor) The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor, thus inducing receptor dimerization and tyrosine autophosphorylation leading to cell proliferation. Mutations in this gene are associated with lung cancer. EGFR is a component of the cytokine storm which contributes to a severe form of Coronavirus Disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). [provided by RefSeq, Jul 2020]
EGFR Gene-Disease associations (from GenCC):
- lung cancerInheritance: AD Classification: DEFINITIVE Submitted by: G2P, Ambry Genetics
- non-small cell lung carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- inflammatory skin and bowel disease, neonatal, 2Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- neonatal inflammatory skin and bowel diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 7-55174889-G-A is Benign according to our data. Variant chr7-55174889-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1191430.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0192 (2931/152286) while in subpopulation NFE AF = 0.0276 (1880/68030). AF 95% confidence interval is 0.0266. There are 33 homozygotes in GnomAd4. There are 1311 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 33 AD,AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EGFR | ENST00000275493.7 | c.2283+69G>A | intron_variant | Intron 19 of 27 | 1 | NM_005228.5 | ENSP00000275493.2 | |||
| EGFR | ENST00000455089.5 | c.2148+69G>A | intron_variant | Intron 18 of 25 | 1 | ENSP00000415559.1 | ||||
| EGFR | ENST00000450046.2 | c.2124+69G>A | intron_variant | Intron 19 of 27 | 4 | ENSP00000413354.2 | ||||
| EGFR | ENST00000700145.1 | c.630+69G>A | intron_variant | Intron 6 of 8 | ENSP00000514824.1 |
Frequencies
GnomAD3 genomes AF: 0.0193 AC: 2935AN: 152168Hom.: 33 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2935
AN:
152168
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0227 AC: 24725AN: 1091130Hom.: 356 AF XY: 0.0227 AC XY: 12685AN XY: 559150 show subpopulations
GnomAD4 exome
AF:
AC:
24725
AN:
1091130
Hom.:
AF XY:
AC XY:
12685
AN XY:
559150
show subpopulations
African (AFR)
AF:
AC:
243
AN:
26016
American (AMR)
AF:
AC:
681
AN:
43402
Ashkenazi Jewish (ASJ)
AF:
AC:
790
AN:
23660
East Asian (EAS)
AF:
AC:
1
AN:
37834
South Asian (SAS)
AF:
AC:
1219
AN:
78330
European-Finnish (FIN)
AF:
AC:
463
AN:
52292
Middle Eastern (MID)
AF:
AC:
230
AN:
5054
European-Non Finnish (NFE)
AF:
AC:
19912
AN:
776182
Other (OTH)
AF:
AC:
1186
AN:
48360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1348
2696
4045
5393
6741
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
584
1168
1752
2336
2920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0192 AC: 2931AN: 152286Hom.: 33 Cov.: 33 AF XY: 0.0176 AC XY: 1311AN XY: 74450 show subpopulations
GnomAD4 genome
AF:
AC:
2931
AN:
152286
Hom.:
Cov.:
33
AF XY:
AC XY:
1311
AN XY:
74450
show subpopulations
African (AFR)
AF:
AC:
409
AN:
41552
American (AMR)
AF:
AC:
278
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
133
AN:
3470
East Asian (EAS)
AF:
AC:
2
AN:
5188
South Asian (SAS)
AF:
AC:
72
AN:
4818
European-Finnish (FIN)
AF:
AC:
74
AN:
10612
Middle Eastern (MID)
AF:
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1880
AN:
68030
Other (OTH)
AF:
AC:
54
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
145
290
435
580
725
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
32
AN:
3474
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 16, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.